Table 2. Patient demographics.
Total (n = 49) | BTX Only (n = 32) | BTX and Myotomy (n = 17) | |
---|---|---|---|
Male | 19 (39%) | 9 (28%) | 10 (58%) |
Female | 30 (61%) | 23 (71%) | 7 (41%) |
Number deceased | 8 (16%) | 6 (19%) | 2 (12%) |
Mean age and range (y) | 59 (27-91) | 61 (34-91) | 54 (27-83) |
Feeding tube | 7 (14%) | 3 (9%) | 4 (23%) |
Aspiration pneumonia | 5 (10%) | 2 (6%) | 3 (18%) |
Prior head and neck irradiation | 4 (8%) | 3 (9%) | 1 (6%) |
Prior head and neck surgery | 15 (30%) | 7 (22%) | 8 (47%) |
Prior CVA | 2 (4%) | 0 | 2 (12%) |
History of neurodegenerative disease | 24 (49%) | 17 (53%) | 7 (41%) |
Esophageal dysfunction or dysmotility | 12 (24%) | 9 (28%) | 3 (18%) |
BTX — botulinum toxin.